Hi HS, both companies do have GMP manufactured drug stock approved by FDA. I get it with in vitro (this data), but you can’t just take a novel patented drug, test it & put out data on 2 publicly listed companies (one on the NASDAQ) without the other being aware or vice/versa. Glad DXB put in that patent application for potentially the new gold standard over ARB. You can’t just cook up a compound & go with it. Dimerix might be ridiculed for many things, but rushing the gun & lack of professionalism & process in clinical trials, no way.
- Forums
- ASX - By Stock
- DXB
- Ann: DMX-200 Competitive Position Further Enhanced
Ann: DMX-200 Competitive Position Further Enhanced, page-64
-
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add DXB (ASX) to my watchlist
|
|||||
Last
43.5¢ |
Change
-0.015(3.33%) |
Mkt cap ! $239.5M |
Open | High | Low | Value | Volume |
43.5¢ | 43.8¢ | 42.0¢ | $988.7K | 2.301M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 10000 | 43.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
43.5¢ | 17061 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 10000 | 0.430 |
4 | 162352 | 0.425 |
14 | 308110 | 0.420 |
8 | 226373 | 0.415 |
8 | 199251 | 0.410 |
Price($) | Vol. | No. |
---|---|---|
0.435 | 17061 | 1 |
0.440 | 17062 | 1 |
0.445 | 45000 | 2 |
0.450 | 218895 | 3 |
0.455 | 45000 | 1 |
Last trade - 16.10pm 04/09/2024 (20 minute delay) ? |
Featured News
DXB (ASX) Chart |